The global demand for Statins Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020-2026.
The Statins are HMG-CoA reductase inhibitors, a class of lipid lessening medications that reduce poor health and other risks in those who are prone to cardiovascular diseases. They are the most widely used cholesterol lowering drugs. Low density Lipoproteins (LDL), are responsible for the growth of atherosclerosis and coronary heart diseases. Statins are effective against the LDL Cholesterol that result in cardiovascular diseases.
The rapid urbanization is leading the mankind towards a fast paced life. This is resulting in adaption of junk food and ready to eat food which substantially is increasing the rate of heart diseases in population. Additionally, government initiatives like cholesterol awareness campaigns and technological advancement in the healthcare facilities is boosting the market. However, the side effects of statins on human body is the likely to restrain the market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each type, therapeutic area, drug class, applications and distribution segment in the global market of statins.
The entire statins market has been sub-categorized into type, therapeutic area, drug class, applications and distribution. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Therapeutic Area
- Natural Statins
- Synthetic Statins
By Drug Class
- Cardiovascular Disorders
- Inflammatory Disorders
By Distribution Channel
This section covers regional segmentation which accentuates on current and future demand for Statins market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Statins Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Statins market include Abbott Laboratories, AstraZeneca, Aurobindo Pharma, Biocon, GlaxoSmithKline, Merck & Co., Novartis, Pfizer, etc., and Others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.